Can pressing these points ease sickle cell pain?
NCT ID NCT06511453
First seen Jun 24, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study tests whether people with sickle cell disease can reduce their pain by doing acupressure on themselves at home using a simple tool called AcuWand. Three hundred adults will either perform real or sham acupressure every other day for five weeks. The goal is to see if this technique lowers pain intensity and interference in daily life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Acupressure using a tool called AcuWand
- What this could lead to
- If it works, this could offer a simple, drug-free way to manage chronic pain in sickle cell disease at home.
- What could go wrong
- This is an early-stage trial with a sham comparison, so results may show no benefit. Pain is subjective, and the effect may vary widely among participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University School of Medicine
Indianapolis, Indiana, 46075, United States
-
University of California, Irvine
Irvine, California, 92868, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Co-Designed support help parents embrace sickle cell care?
- Can community hospitals in zambia master severe disease care?
- A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?
- Can a phone app keep teens on track with sickle cell treatment?
- A common amino acid may calm sickle cell pain crises — a trial puts it to the test
- A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease